Since 1973, the ALLG and its members have delivered world-class clinical trials and continue to advance the treatment, care and quality of life for patients with blood cancer. The ALLG’s National Blood Cancer Registry (NBCR) is the largest holding of real-world acute myeloid leukaemia (AML) data in Australia and New Zealand. Connect with us today to learn more about how we deliver better treatments and better lives through our range of collaborative clinical trials and translational research initiatives.